Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NPFFR1 | Q9GZQ6 | 1/20 | 0.31 |
| ▸ | NPFFR2 | Q9Y5X5 | 1/20 | 0.31 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.31 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.31 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.31 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.31 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3843497 | 0.87 | — | — | |
| SCHEMBL3846937 | 0.85 | — | — | |
| SCHEMBL4437737 | 0.84 | NPFFR1 (0.31) | NPFFR1NPFFR2GRIN2DGRIN3BGRIN1 | |
| SCHEMBL6354923 | 0.84 | PKM (0.47) | MEN1ALDH1A1KMT2ANPFFR1NPFFR2 | |
| SCHEMBL4102744 | 0.82 | — | — | |
| SCHEMBL960382 | 0.82 | GRIN2D (0.38) | NPFFR1NPFFR2GRIN2DGRIN3BGRIN1 | |
| Water SCHEMBL4022360 | 0.80 | NPFFR1 (0.37) | NPFFR1NPFFR2GRIN2DGRIN3BGRIN1 | |
| SCHEMBL23051570 | 0.79 | MEN1 (0.39) | MEN1ALDH1A1KMT2AGRIN2DGRIN3B | |
| SCHEMBL7733776 | 0.77 | — | — | |
| SCHEMBL3848004 | 0.77 | LMNA (0.32) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110770282-A | Curable silicone composition, and application and use thereof | 莫门蒂夫性能材料股份有限公司 | 2020-02-07 | — | — | CN | claimed |
| US-10385210-B2 | Curable silicone composition and applications and uses thereof | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2019-08-20 | — | — | US | claimed |
| US-10287400-B2 | Curable silicone composition and applications and uses thereof | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2019-05-14 | — | — | US | claimed |
| EP-3443027-A1 | CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF | Momentive Performance Materials Inc. (US) | 2019-02-20 | — | — | EP | claimed |
| CN-109312077-A | Curable silicon composition and its application and use | 莫门蒂夫性能材料股份有限公司 | 2019-02-05 | — | — | CN | claimed |
| WO-2017180329-A1 | CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2017-10-19 | — | — | WO | claimed |
| US-20170298188-A1 | CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. | 2017-10-19 | — | — | US | claimed |
| CN-110770282-A | Curable silicone composition, and application and use thereof | 莫门蒂夫性能材料股份有限公司 | 2020-02-07 | — | — | CN | disclosed |
| US-10287400-B2 | Curable silicone composition and applications and uses thereof | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2019-05-14 | — | — | US | disclosed |
| EP-3443027-A1 | CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF | Momentive Performance Materials Inc. (US) | 2019-02-20 | — | — | EP | disclosed |
| CN-109312077-A | Curable silicon composition and its application and use | 莫门蒂夫性能材料股份有限公司 | 2019-02-05 | — | — | CN | disclosed |
| US-20170298188-A1 | CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. | 2017-10-19 | — | — | US | disclosed |
| WO-2017180329-A1 | CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2017-10-19 | — | — | WO | disclosed |
| EP-0990634-B1 | ACYLATING AGENTS, ACYLATION METHOD WITH THE USE OF THE SAME AND ADAMANTANE DERIVATIVES | DAICEL CHEM (JP) | 2013-04-10 | — | — | EP | disclosed |
| US-7309752-B2 | Polymer and film forming composition | FUJIFILM CORPORATION (JP) | 2007-12-18 | — | — | US | disclosed |
| US-20070073019-A1 | Polymer and film forming composition | FUJI PHOTO FILM CO., LTD. | 2007-03-29 | — | — | US | disclosed |
| US-6429314-B1 | USING 1,2-DICARBONYL DERIVATIVE OR ITS HYDROXY REDUCTIVE, OXYGEN, COBALT ACETATE METAL COMPOUND, AND N-HYDROXYPHTHALIMIDE OR OTHER IMIDE DERIVATIVE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-08-06 | — | — | US | disclosed |
| EP-0990634-A1 | ACYLATING AGENTS, ACYLATION METHOD WITH THE USE OF THE SAME AND ADAMANTANE DERIVATIVES | Daicel Chemical Industries, Ltd. (JP) | 2000-04-05 | — | — | EP | disclosed |
| US-4918158-A | HEAT RESISTANCE; DIELECTRICS, MATRICES, AEROSPACE | FLUOROCHEM INC. (US) | 1990-04-17 | — | — | US | disclosed |
| US-4849565-A | 1,3-diethynyladamantane and methods of polymerization thereof | BAUM KURT (US) | 1989-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170298188-A1 | CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF | VCL, CCNI, SMCHD1 | MEN1 2151/4885ALDH1A1 1443/4885KMT2A 2275/4885 |
| US-10287400-B2 | Curable silicone composition and applications and uses thereof | VCL, CCNI, SMCHD1 | MEN1 2151/4885ALDH1A1 1443/4885KMT2A 2275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.